What is the recommended frequency for Nicotinamide adenine dinucleotide (NAD+) intravenous (IV) infusions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

NAD+ IV infusions should be administered once or twice weekly during an initial treatment phase, followed by maintenance sessions every 2-4 weeks, as this frequency has been shown to be effective in maintaining elevated NAD+ levels and improving health outcomes 1. The frequency of NAD+ IV infusions depends on individual health goals, age, and specific conditions being addressed.

  • A standard protocol might include 4-10 initial sessions (often daily or every other day), then transitioning to less frequent maintenance treatments.
  • Each infusion generally lasts 2-4 hours, with dosages ranging from 500-1000mg per session. However, there is limited standardization in protocols as NAD+ therapy is still considered experimental. The rationale for spacing treatments is to maintain elevated NAD+ levels, which naturally decline with age and are associated with cellular energy production and DNA repair. It's essential to note that NAD+ IV therapy should only be administered by qualified healthcare providers, as improper administration can cause side effects like flushing, nausea, or headaches. Before starting NAD+ infusions, patients should consult with a healthcare provider to determine an appropriate schedule based on their specific health needs and medical history, as supported by recent studies 2, 3. Additionally, research has shown that NAD+ supplementation can have beneficial effects on physiological changes and diseases associated with aging, including chronic fatigue syndrome, older adults, Parkinson's disease, overweight, postmenopausal prediabetes, and Alzheimer's disease 1, 4. A recent study also investigated the changes in human plasma and urine NAD+ metabolome during a 6-hour intravenous infusion of NAD+, providing valuable insights into the fate of directly infused NAD+ in humans 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.